06 April 2023 : Clinical Research
Evaluation of the Impact of Remote Monitoring Using the Sharesource Connectivity Platform on Adherence to Automated Peritoneal Dialysis in 51 Patients
Min-Yu Chang12AEF, Po-Jui Chi123ABCD, Hsi-Hao Wang12A, Yi-Che Lee12A, Li-Chun Ho12F, Ching-Fang Wu124CD, Ching-Yang Chen12DF, Hung-Hsiang Liou15AF, Shih-Yuan Hung
16AD*
DOI: 10.12659/MSM.939523
Med Sci Monit 2023; 29:e939523
Figure 1 Study design. Patients were maintained on a traditional automated peritoneal dialysis machine (HomeChoice, Baxter Healthcare Corporation, Deerfield, IL, USA) for at least 1 week (phase 1), and then changed to HomeChoice Claria (Baxter Healthcare Corporation, Deerfield, IL, USA) without Sharesource for 12 weeks (phase 2). The machines were then connected to Sharesource for another 12 weeks (phase 3). Patients were followed up for 1 year. (Designed in Microsoft Word and converted to JPG).